These findings go on to suggest that CCND1 and CDK6 play a vital role in HNSCC, are involved in tumor progression and can be used as a clinical biomarkers for advanced stages of HNSCC. This evidence concerns the gene CDK6 and head and neck squamous cell carcinoma.